Randomized Study in Children and Adolescents With Migraine: Acute Treatment
for Pediatric Migraine
84 locations incl. Scottsdale
Sponsor: Pfizer
Sex: All·Age: 6 - 17
Code: NCT04649242·Phase 3·Recruiting·Listed Dec 2020
SCLA Management
Clinical research site in Houston, Texas · 3 RIVERWAY, SUITE 1810, HOUSTON, TX 77056-1919 · (713) 572-2222
Part of SCLA Management
As of July 2026, 2 paid clinical trials are recruiting at SCLA Management in Houston, Texas. Active studies at this site cover conditions such as Pediatric Migraine and Acute Treatment of Migraine. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at SCLA Management (2)
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
for Acute Treatment of Migraine
64 locations incl. Scottsdale
Sponsor: Pfizer
Sex: All·Age: 6 - 17
Code: NCT04743141·Phase 3·Recruiting·Listed Feb 2021
More research sites in Houston
- MD Anderson Cancer Center (422 trials)
- M D Anderson Cancer Center (272 trials)
- Baylor College of Medicine (197 trials)
- The University of Texas Health Science Center at Houston (185 trials)
- The University of Texas MD Anderson Cancer Center (131 trials)
- Houston Methodist Hospital (128 trials)
- Texas Children's Hospital (113 trials)
- The University of Texas M. D. Anderson Cancer Center (85 trials)
- University of Texas MD Anderson Cancer Center (83 trials)
- UT MD Anderson Cancer Center (62 trials)